Cargando…
High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.
Symptomatic brain metastases are found in about 40% of patients with small cell lung cancer. Cranial irradiation is the first line treatment for this form of metastatic disease. Frequently brain metastases recur after this treatment or develop after prophylactic cranial irradiation. For these patien...
Autores principales: | Postmus, P. E., Haaxma-Reiche, H., Sleijfer, D. T., Kirkpatrick, A., McVie, J. G., Kleisbauer, J. P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246989/ https://www.ncbi.nlm.nih.gov/pubmed/2539174 |
Ejemplares similares
-
Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.
por: van Meerbeeck, J., et al.
Publicado: (1996) -
Cancer information on the Internet
por: McVie, Gordon
Publicado: (2007) -
Progress and perspectives in chemoprevention of cancer seroni symposia publications, Vol. 79
por: McVie, J.G.
Publicado: (1994) -
Highlights from the ecancer Future Horizons in Lung Cancer conference, 1–2 September 2016: Focusing on the future of treatment for NSCLC and SCLC
por: Bassiri, Kayleigh, et al.
Publicado: (2017) -
Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer.
por: Lee, C. R., et al.
Publicado: (1993)